Skip to main content

Table 1 Patient characteristics

From: Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases

Patient characteristics

Patients who received peri-operative chemotherapy

Patients who underwent surgery alone

Total cohort

Number of patients

38

13

51

Number of pulmonary resections

56

16

72

Age median (range)

61.4 (41–78)

65 (49–78)

63 (41–78)

Male:female

23:15

7:6

30:21

Site of primary

   

 Colon

20

7

27

 Rectum

18

6

24

Stage at diagnosis

   

 Stage II

8

6

14

 Stage III

20

4

24

 Stage IV

11

3

14

 Site of metastases

   

 Liver

2

3

5

 Lung

8

0

8

 Lung + Omentum

1

0

1

Adjuvant chemotherapy for primary CRC

Yes

24

7

31

 With neoadjuvant CRT

3

4

7

 With neoadjuvant chemo + CRT

3

0

3

 With Adjuvant RT

0

1

1

No

8

1

9

Site of first metastases

   

 Lung only

29

10

39

 Lung + liver

2

0

2

 Liver only

5

3

8

 Peritoneum

1

0

1

 Nodal (para-aortic)

1

0

1

CEA pre-treatment*

   

 Recorded

35 (49 resections)

10 (12 resections)

45 (61 resections)

 Not Recorded

3 (7 resections)

3 (4 resections)

6 (11 resections)

 >institutional ULN

7 (8 resections)

2 (2 resections)

9 (10 resections)

 Median CEA (range)

2 μg/dl (1–1094)

1.5 μg/dl (<1-10)

2 μg/dl (<1-1094)

  1. Numbers in table refer to number of patients unless otherwise specified.
  2. *either prior to neoadjuvant chemotherapy or prior to surgery if no neoadjuvant chemotherapy given.